MedPath

Prospective randomized controlled trial to evaluate the effect of tranexamic acid in irrigant solution on perioperative blood loss during mini-percutaneous nephrolithotomy

Phase 1
Conditions
Patients who have renal calculi and undergo mini-percutaneous nephrolithotomy
Tranexamic acid
Irrigant solution
Mini-Percutaneous nephrolithotomy
Perioperative blood loss
Registration Number
TCTR20211021003
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
50
Inclusion Criteria

Adult patients age 18 years or older who undergo mini-PCNL

Exclusion Criteria

1) hypersensitivity to TXA
2) early pregnancy
3) disturbances of color vision
4) massive bleeding in the upper tract
5) acute arterial or venous thrombosis
6) severe renal impairment
7) history of convulsion
8) subarachnoid hemorrhage
9) intrathecal and intraventricular injection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Perioperative blood loss during mini-PCNL 24 hr post op Hemoglobin loss, requirement of blood transfusion
Secondary Outcome Measures
NameTimeMethod
Complication from mini-PcNL 3-5 days Fever, pneumothorax, bowel perforate
© Copyright 2025. All Rights Reserved by MedPath